Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-22-049866

Chief Financial Officer bought 30,000 shares at an average $2.61 ($78,414)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Byam Rebecca Chief Financial Officer 2022-09-12 Purchase +15,000 $2.65 $39,764 297,952 D
Byam Rebecca Chief Financial Officer 2022-09-13 Purchase +15,000 $2.58 $38,651 312,952 D
Open-market purchases · 30,000 sh · avg $2.61 · $78,414
Loading xslF345X03/doc4.xml…